We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$19.9B
AUM Growth
+$1.62B
Cap. Flow
-$35.6M
Cap. Flow %
-0.18%
Top 10 Hldgs %
43.73%
Holding
208
New
17
Increased
41
Reduced
35
Closed
35

Top Buys

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$384M
2
VMW
VMware, Inc
VMW
+$286M
3
UNH icon
UnitedHealth
UNH
+$192M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$158M
5
IQV icon
IQVIA
IQV
+$132M

Top Sells

Rank Stock Value
1
SJR
Shaw Communications Inc.
SJR
+$473M
2
DT icon
Dynatrace
DT
+$329M
3
CRM icon
Salesforce
CRM
+$318M
4
MSFT icon
Microsoft
MSFT
+$253M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$191M

Sector Composition

Rank Sector Weight
1 Healthcare 35.32%
2 Technology 16.45%
3 Financials 12.17%
4 Industrials 7.23%
5 Communication Services 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BX icon
26
Blackstone
BX
$107B
$284M 1.43%
3,058,251
-81,700
-3% -$7.06M
NOW icon
27
ServiceNow
NOW
$121B
$279M 1.4%
2,485,250
-1,013,000
-29% -$101M
BSX icon
28
Boston Scientific
BSX
$71.4B
$273M 1.37%
5,045,257
-2,660,000
-35% -$139M
EFX icon
29
Equifax
EFX
$20.7B
$249M 1.25%
1,058,697
-337,900
-24% -$71.1M
V icon
30
Visa
V
$692B
$247M 1.24%
1,039,310
+29,900
+3% +$6.84M
CSGP icon
31
CoStar Group
CSGP
$12B
$245M 1.23%
2,751,056
-660,129
-19% -$51M
XYZ
32
Block Inc
XYZ
$47B
$223M 1.12%
3,344,050
+483,000
+17% +$30.2M
ELV icon
33
Elevance Health
ELV
$84.9B
$198M 0.99%
445,330
-228,300
-34% -$105M
BIIB icon
34
Biogen
BIIB
$30.5B
$172M 0.86%
604,098
-15,700
-3% -$4.67M
BABA icon
35
Alibaba
BABA
$304B
$156M 0.78%
1,870,000
+70,000
+4% +$6.13M
SRPT icon
36
Sarepta Therapeutics
SRPT
$1.77B
$138M 0.69%
1,205,200
+291,900
+32% +$37.6M
SGEN
37
DELISTED
Seagen Inc. Common Stock
SGEN
$135M 0.68%
700,000
+475,000
+211% +$94.4M
SYNH
38
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$130M 0.65%
3,075,000
+2,603,000
+551% +$105M
PTGX icon
39
Protagonist Therapeutics
PTGX
$9.4B
$125M 0.63%
4,511,430
+1,896,416
+73% +$47.5M
HUM icon
40
Humana
HUM
$44.1B
$116M 0.58%
258,461
+13,800
+6% +$6.95M
LNTH icon
41
Lantheus
LNTH
$6.6B
$114M 0.57%
1,360,500
+1,176,500
+639% +$106M
PACB icon
42
Pacific Biosciences
PACB
$363M
$111M 0.56%
8,338,120
+1,983,000
+31% +$24.1M
BEAM icon
43
Beam Therapeutics
BEAM
$2.81B
$110M 0.55%
3,441,522
+9,601
+0.3% +$312K
INSP icon
44
Inspire Medical Systems
INSP
$1.7B
$105M 0.53%
323,096
+80,500
+33% +$23M
ISEE
45
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$96.1M 0.48%
2,442,299
+1,957,500
+404% +$69.1M
PCG icon
46
PG&E
PCG
$37.4B
$86.5M 0.43%
5,005,142
– –
HCA icon
47
HCA Healthcare
HCA
$88.5B
$79.6M 0.4%
262,400
+105,800
+68% +$29.4M
AGIO icon
48
Agios Pharmaceuticals
AGIO
$1.91B
$76.1M 0.38%
2,688,829
+596,000
+28% +$14.8M
RVMD icon
49
Revolution Medicines
RVMD
$42.1B
$74.5M 0.37%
2,783,480
-500,120
-15% -$12.3M
BEKE icon
50
KE Holdings
BEKE
$18.7B
$70.7M 0.35%
4,758,500
– –
1
2
3 4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Farallon Capital Management held 208 positions worth $19.9B, up 8.8% from $18.3B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Farallon Capital Management's Q2 2023 filing shows 17 new, 41 increased, 35 reduced and 35 closed positions. Its largest new stake was Analog Devices: 2,075,000 shares worth $404M. The largest sale was Shaw Communications Inc., an estimated $473M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Farallon Capital Management's largest Q2 2023 buy was Analog Devices: 2,075,000 shares worth $404M.
  • Farallon Capital Management added most to VMware, Inc in Q2 2023, an estimated $286M increase.
  • Farallon Capital Management's biggest Q2 2023 reduction was Salesforce, cutting an estimated $318M.
  • Farallon Capital Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $473M.
  • Farallon Capital Management's ten largest holdings make up 44% of its $19.9B portfolio in Q2 2023.
  • Farallon Capital Management opened 17 new positions and closed 35 in Q2 2023.
  • Farallon Capital Management's portfolio value rose 8.8% quarter-over-quarter to $19.9B.

Based on Farallon Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.